RééDOC
75 Boulevard Lobau
54042 NANCY cedex

Christelle Grandidier Documentaliste
03 83 52 67 64


F Nous contacter

0

Article

--";3! O

F x |

     

-A +A

French consensus : Treatment of newly diagnosed restless legs syndrome

LIMOUSIN N; FLAMAND M; SCHRODER C; CHARLEY MONACA C
REV NEUROL (Paris) , 2018, vol. 174, n° 7-8, p. 515-521
Doc n°: 188350
Localisation : Documentation IRR

D.O.I. : http://dx.doi.org/DOI:10.1016/j.neurol.2018.06.002
Descripteurs : DE65 - PATHOLOGIE - TIBIA-PERONE, AD72 - TROUBLES DU SOMMEIL

Treatment of restless legs syndrome (RLS) must only be considered after a
definite positive diagnosis. The RLS phenotype must be characterised precisely,
iron deficiency always tested for, and aggravating factors eliminated when
possible. Medical treatment is considered for severe or very severe forms and
based on dopaminergic agonists, alpha2delta-1 ligands and/or opioids. First line
treatment will be a low-dose monotherapy and the choice of treatment depends on
the results of the clinical examination and investigations.
CI - Copyright (c) 2018. Published by Elsevier Masson SAS.

Langue : ANGLAIS

|

Ajouter au panier

4

Gerer mes paniers

|

Signaler une erreur

Mes paniers

4

Gerer mes paniers

0